BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20682803)

  • 1. Henipavirus: a review of laboratory animal pathology.
    Williamson MM; Torres-Velez FJ
    Vet Pathol; 2010 Sep; 47(5):871-80. PubMed ID: 20682803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of henipavirus infection: a review.
    Weingartl HM; Berhane Y; Czub M
    Vet J; 2009 Sep; 181(3):211-20. PubMed ID: 19084436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model.
    Guillaume V; Wong KT; Looi RY; Georges-Courbot MC; Barrot L; Buckland R; Wild TF; Horvat B
    Virology; 2009 May; 387(2):459-65. PubMed ID: 19328514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in experimental animal models of Henipavirus infection.
    Rockx B
    Pathog Dis; 2014 Jul; 71(2):199-206. PubMed ID: 24488776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments towards effective treatments for Nipah and Hendra virus infection.
    Bossart KN; Broder CC
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):43-55. PubMed ID: 16441208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
    Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
    Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal challenge models of henipavirus infection and pathogenesis.
    Geisbert TW; Feldmann H; Broder CC
    Curr Top Microbiol Immunol; 2012; 359():153-77. PubMed ID: 22476556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hendra virus and Nipah virus animal vaccines.
    Broder CC; Weir DL; Reid PA
    Vaccine; 2016 Jun; 34(30):3525-34. PubMed ID: 27154393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
    Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines to Emerging Viruses: Nipah and Hendra.
    Amaya M; Broder CC
    Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
    Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
    J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal Models for Henipavirus Research.
    Pigeaud DD; Geisbert TW; Woolsey C
    Viruses; 2023 Sep; 15(10):. PubMed ID: 37896758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferon signaling protects mice from lethal henipavirus infection.
    Dhondt KP; Mathieu C; Chalons M; Reynaud JM; Vallve A; Raoul H; Horvat B
    J Infect Dis; 2013 Jan; 207(1):142-51. PubMed ID: 23089589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines.
    Ploquin A; Szécsi J; Mathieu C; Guillaume V; Barateau V; Ong KC; Wong KT; Cosset FL; Horvat B; Salvetti A
    J Infect Dis; 2013 Feb; 207(3):469-78. PubMed ID: 23175762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.
    Fischer K; Diederich S; Smith G; Reiche S; Pinho Dos Reis V; Stroh E; Groschup MH; Weingartl HM; Balkema-Buschmann A
    PLoS One; 2018; 13(4):e0194385. PubMed ID: 29708971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefusion stabilization of the Hendra and Langya virus F proteins.
    Byrne PO; Blade EG; Fisher BE; Ambrozak DR; Ramamohan AR; Graham BS; Loomis RJ; McLellan JS
    J Virol; 2024 Feb; 98(2):e0137223. PubMed ID: 38214525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in henipavirus research: molecular biology, genetic diversity, animal models.
    Rockx B; Winegar R; Freiberg AN
    Antiviral Res; 2012 Aug; 95(2):135-49. PubMed ID: 22643730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.
    Rockx B; Bossart KN; Feldmann F; Geisbert JB; Hickey AC; Brining D; Callison J; Safronetz D; Marzi A; Kercher L; Long D; Broder CC; Feldmann H; Geisbert TW
    J Virol; 2010 Oct; 84(19):9831-9. PubMed ID: 20660198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-Linked Immunosorbent Assay Using Henipavirus-Receptor EphrinB2 and Monoclonal Antibodies for Detecting Nipah and Hendra Viruses.
    Zhu W; Smith G; Pickering B; Banadyga L; Yang M
    Viruses; 2024 May; 16(5):. PubMed ID: 38793674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indiscriminate activities of different henipavirus polymerase complex proteins allow for efficient minigenome replication in hybrid systems.
    Li X; Yang Y; López CB
    J Virol; 2024 Jun; 98(6):e0050324. PubMed ID: 38780245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.